These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 2531149)

  • 1. Quantification of dopamine D2 receptors by irreversible tracer binding in the living human brain: the model-dependent correction of metabolites.
    Swart JA; Korf J
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):906-8; author reply 908-10. PubMed ID: 2531149
    [No Abstract]   [Full Text] [Related]  

  • 2. [The distribution of dopamine D1 and D2 receptors in the brain of rodents and carnivores].
    Avgustinovich DF; Nikulina EM
    Zh Evol Biokhim Fiziol; 1992; 28(1):3-8. PubMed ID: 1387995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specific binding of 3H-domperidone--a selective ligand of D2-dopamine receptors--by the human caudate nucleus].
    Zlobina GP; Chekalina ND
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(7):1043-5. PubMed ID: 2960110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute quantification by positron emission tomography of the endogenous ligand.
    Delforge J; Bottlaender M; Pappata S; Loc'h C; Syrota A
    J Cereb Blood Flow Metab; 2001 May; 21(5):613-30. PubMed ID: 11333372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dopamine receptors].
    Terai M; Usuda S; Maeno H
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1328-37. PubMed ID: 6241319
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.
    Endres CJ; Kolachana BS; Saunders RC; Su T; Weinberger D; Breier A; Eckelman WC; Carson RE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):932-42. PubMed ID: 9307606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quantitative analysis of D2-dopamine receptors in baboon striatum in vivo with 3-N-[2'-18F]fluoroethylspiperone using positron emission tomography.
    Jovkar S; Wienhard K; Pawlik G; Coenen HH
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):720-6. PubMed ID: 2384543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study.
    Levant B; Grigoriadis DE; DeSouza EB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):991-1001. PubMed ID: 8437136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
    J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and distribution of [125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain.
    Joyce JN; Janowsky A; Neve KA
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1253-63. PubMed ID: 1828505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride, a high-affinity substituted benzamide ligand.
    Neve KA; Henningsen RA; Kinzie JM; De Paulis T; Schmidt DE; Kessler RM; Janowsky A
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1108-16. PubMed ID: 2138666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine.
    Van Tol HH; Bunzow JR; Guan HC; Sunahara RK; Seeman P; Niznik HB; Civelli O
    Nature; 1991 Apr; 350(6319):610-4. PubMed ID: 1840645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptors. The D4 and schizophrenia.
    Iversen LL
    Nature; 1993 Sep; 365(6445):393. PubMed ID: 8413582
    [No Abstract]   [Full Text] [Related]  

  • 19. Imaging dopamine receptors in the human brain.
    Wagner HN
    Am J Physiol Imaging; 1988; 3(1):63. PubMed ID: 3390359
    [No Abstract]   [Full Text] [Related]  

  • 20. [Correction of a prognostic model].
    Zahorovs'ka LT; Ianishevs'kyĭ AT
    Farm Zh; 1979; (4):60-4. PubMed ID: 477946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.